NEUREN PHARMACEUTICALS LIMITED
Who is NEUREN PHARMACEUTICALS LIMITED?
Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for six debilitating neurodevelopmental disorders that emerge in early childhood and are characterised by impaired connections and signalling between brain cells.
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Address:
CAMBERWELL, VIC 3124, AU
Employees by Department
- IT / Product (3)
- Operations (2)
- The Rest (5)
- Total (10)
Key Decision Makers
Stephanie Terreiro
Associate Clinical Project Manager
Jayde Aston
Senior Accountant
Dianne Angus
Lauren Frazer
Employees by Seniority
C-level
1employees
Senior
3employees
Non-managers
2employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of NEUREN PHARMACEUTICALS LIMITED?
- Where is NEUREN PHARMACEUTICALS LIMITED's headquarter?
- What NEUREN PHARMACEUTICALS LIMITED's spending power?
- Does NEUREN PHARMACEUTICALS LIMITED have a presence in the domain it operates in?